CTS(US:CTS)2025-04-30 12:26Q1 2025 Financial Performance - Revenue remained flat at $126 million compared to Q1 2024[8, 36] - Adjusted gross margin increased by 77 bps to 37%[8, 36] - Adjusted diluted EPS decreased by 7% to $044[8, 36] End Market Analysis - Diversified end markets revenue increased by 14% year-over-year and accounted for 53% of total revenue[11, 39] - Aerospace & Defense sales increased by 13% year-over-year[14] - Medical sales increased significantly by 39% year-over-year[19] - Transportation end market revenue decreased by 12% year-over-year due to lower commercial vehicle sales and China softness[11, 39] Book-to-Bill Ratio and Booked Business - The company's overall book-to-bill ratio was 117[11] - Transportation end market has $1 billion in total booked business at the end of Q1 2025[26] - Medical's book-to-bill ratio was 15 with bookings up 32% year-over-year[19] FY 2025 Guidance - Revenue is projected to be between $520 million and $550 million[28] - Adjusted diluted EPS is expected to be between $220 and $235[30]